Claudia C. Folman
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Cost-effectiveness of cEK-preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus and newborn in the Dutch healthcare setting.
Journal: Vox sanguinis
Published: November 20, 2025
Routine use of a spike-in DNA in-process control for foetal RHD genotyping: Testing the real-world effectiveness of this 'canary'.
Journal: Vox sanguinis
Published: October 07, 2025
Vesiculation as potential novel pathogenic mechanism in autoimmune hemolytic anemia.
Journal: Transfusion
Published: January 15, 2025
Major reduction in occurrence of anti-c and anti-E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c-matching.
Journal: British journal of haematology
Published: July 11, 2024
C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.
Journal: Blood advances
Published: November 23, 2022
Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.
Journal: Transfusion
Published: September 10, 2020
Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies.
Journal: Transfusion
Published: July 25, 2019
Last Updated: 09/26/2026